Polyserase-I, a Human Polyprotease with the Ability to Generate Independent Serine Protease Domains from a Single Translation Product

Total Page:16

File Type:pdf, Size:1020Kb

Polyserase-I, a Human Polyprotease with the Ability to Generate Independent Serine Protease Domains from a Single Translation Product Polyserase-I, a human polyprotease with the ability to generate independent serine protease domains from a single translation product Santiago Cal, Vı´ctorQuesada, Cecilia Garabaya, and Carlos Lo´ pez-Otı´n* Departamento de Bioquı´micay Biologı´aMolecular, Facultad de Medicina, Instituto Universitario de Oncologı´a,Universidad de Oviedo, 33006-Oviedo, Spain Communicated by Pamela J. Bjorkman, California Institute of Technology, Pasadena, CA, June 4, 2003 (received for review February 21, 2003) We have identified and cloned a human liver cDNA encoding an a region of the short arm of chromosome 19. In this work, we unusual mosaic polyprotein, called polyserase-I (polyserine pro- report the finding that these three predicted independent genes tease-I). This protein exhibits a complex domain organization are in fact part of a unique gene encoding a human polyprotease including a type II transmembrane motif, a low-density lipoprotein that we have tentatively called polyserase-I. We also show that receptor A module, and three tandem serine protease domains. polyserase-I undergoes a series of proteolytic processing events This unusual modular architecture is also present in the sequences to yield three independent serine protease domains. This is an predicted for mouse and rat polyserase-I. Human polyserase-I gene example of generation of independent serine protease domains maps to 19p13, and its last exon overlaps with that corresponding in human tissues from a single translation product and illustrates to the 3؅ UTR of the gene encoding translocase of mitochondrial an additional strategy for increasing the complexity of the inner membrane 13. Northern blot analysis showed the presence of human degradome. a major polyserase-I transcript of 5.4 kb in human fetal and adult tissues and in tumor cell lines. Analysis of processing mechanisms Materials and Methods of polyserase-I revealed that it is synthesized as a membrane- Molecular Cloning. A computer search of human genome data- associated polyprotein that is further processed to generate three bases allowed the identification of three regions in the human independent serine protease units. Two of these domains are DNA contig NT࿝011245 (chromosome 19p13), which after con- proteolytically active against synthetic peptides commonly used ceptual translation, showed the presence of structural hallmarks for assaying serine proteases. These proteolytic activities of the for serine proteases. Then, a PCR-based approach to clone polyserase-I units are blocked by serine protease inhibitors. We cDNAs for these proteases was designed. The strategy first show an example of generation of separate serine protease do- involved the use of specific oligonucleotides derived from the mains from a single translation product in human tissues and central putative protease gene present in the cluster. The illustrate an additional mechanism for expanding the complexity of sequences of the designed primers Polys2f, Polys2f-nd, Polys 2r, the human degradome, the entire protease complement of human and Polys2r-nd are indicated in Table 1, which is published as cells and tissues. supporting information on the PNAS web site, www.pnas.org. The PCR was performed in a GeneAmp 2400 PCR system roteases comprise a growing group of structurally and func- (Perkin–Elmer Life Sciences) for 40 cycles of denaturation Ptionally diverse proteins that share a common property: the (94°C, 20 s), annealing (64°C, 15 s), and extension (68°C, 60 s). Ͼ ability to hydrolyze peptide bonds (1). To date, 500 different The amplified PCR product (439 bp) from a human liver cDNA human proteases and protease homologs have been identified (2, library was cloned and sequenced. The 5Ј and 3Ј ends of the 3). Functional studies involving this large group of enzymes were cloned cDNA were extended by successive rounds of rapid originally aimed at analyzing their role in nonspecific reactions amplification of cDNA ends (RACE) by using RNA from human associated with protein catabolism. However, over recent years, liver and the Marathon cDNA amplification kit (CLONTECH). it has been widely recognized that proteolysis represents a Sequence analysis of the RACE-extended cDNA clones led us to fundamental mechanism for regulating many events on which conclude that the two additional protease genes present at the cell life and death depend. Thus, proteases through their ability 5Ј and 3Ј ends of the central protease gene of the NT࿝011245 to perform highly selective and limited cleavage of specific DNA contig were in fact part of a single gene encoding a protein substrates may control the appropriate intracellular or extracel- with three protease-like domains. Once the start and stop codons lular localization of multiple proteins, the ectodomain shedding of this large gene were located, the full-length cDNA was from membrane-bound proteins, or the activation and inactiva- BIOCHEMISTRY obtained by PCR using the primers polysATG and polysEND tion of cytokines, growth factors, and peptide hormones (2, 3). (Table 1). PCR conditions were as above, but with 180 s of These proteolytic processing events influence essential biologi- extension. cal processes including cell-cycle progression, morphogenesis, tissue remodeling, cell proliferation, cell migration, angiogene- ϩ Northern Blot Analysis. Nylon filters containing poly(A) RNA of sis, and apoptosis (4–8). Furthermore, alterations in the struc- diverse human tissues were prehybridized at 42°C for 3 h in 50% ture, function, and regulation of proteases underlie several ϫ ͞ human diseases such as cancer, arthritis, cardiovascular disor- formamide, 5 standard saline phosphate EDTA (0.18 M NaCl͞10 mM phosphate, pH 7.4͞1 mM EDTA), 10ϫ Denhardt’s ders, and neurodegenerative diseases (9–13). ␮ ͞ The increasing complexity of human proteolytic systems has solution, 2% SDS, and 100 g ml denatured herring sperm made necessary the introduction of global concepts and ap- DNA. Hybridization was performed with a 0.5-kb radiolabeled proaches to try to clarify the multiple questions that have arisen in the protease field. Thus, we have coined the term degradome Abbreviations: HA, hemagglutinin; LDLR, low-density lipoprotein receptor; TTSP, type II to define the complete set of proteases that are produced at a transmembrane serine protease; ACE, angiotensin-converting enzyme; AMC, 7-amino-4- specific moment or circumstance by a cell, tissue, or organism methylcoumarin. (2). Recently, and as part of our studies focused on trying to get Data deposition: The sequences reported in this paper have been deposited in the GenBank a complete view of the human degradome, we observed the database (accession nos. AJ488946 and AJ488947). presence of three putative serine protease genes closely linked at *To whom correspondence should be addressed. E-mail: [email protected]. www.pnas.org͞cgi͞doi͞10.1073͞pnas.1633392100 PNAS ͉ August 5, 2003 ͉ vol. 100 ͉ no. 16 ͉ 9185–9190 Downloaded by guest on September 26, 2021 probe amplified from the cDNA clone with oligonucleotides northF and northR (Table 1). After hybridization for 20 h under the same conditions used for prehybridization, filters were washed with 0.1ϫ SSC, 0.1% SDS for2hat50°C, and Fig. 1. Structure of polyserase-I. TM, transmembrane domain; LDLR, LDLR A autoradiographed. module; serase, serine protease domain. Production and Purification of Recombinant Proteins. Two cDNA contructs encoding the first or the second serine protease domains tification of a DNA contig containing three regions putatively of the cloned cDNA were generated by PCR amplification using the encoding new serine proteases. However, detailed sequence oligonucleotides mod1f, mod1r, mod2f, and mod2r (Table 1). The analysis of these three regions revealed that they were very close PCR amplifications were performed for 25 cycles of denaturation to each other, suggesting that they could be part of a single gene (95°C, 15 s), annealing (59°C, 10 s), and extension (68°C, 50 s). The containing different protease modules. To explore this possibil- PCR products were cloned in the SmaI site of the pGEX-3X ity, we performed PCR amplifications with specific oligonucle- expression vector (Amersham Pharmacia Biosciences). The result- otides derived from the central protease module, followed by Ј Ј ing vectors, pGEX-3X-serase-1 and pGEX-3X-serase-2, were successive rounds of 5 and 3 rapid amplifications of cDNA transformed into BL21(DE3)pLysE Escherichia coli cells, and ends. This strategy led us to generate a cDNA of 3,180 bp, which expression was induced by isopropyl ␤-D-thiogalactoside. The re- after cloning and sequencing, revealed the presence of a single combinant proteins were purified on a glutathione-Sepharose 4B RNA transcript containing the coding information for the three column and used for enzymatic assays. predicted serine protease domains (Fig. 1). Computer analysis of this cDNA sequence demonstrated that it codes for a protein of Protease Assays. The putative enzymatic activity of the recombinant 1,059 aa, with a calculated molecular weight of 114,020. The GST-serase-1 and GST-serase-2 proteins was analyzed by using the proposed AUG initiation codon is located in a context (GC- synthetic fluorescent substrates N-t-Boc-Gln-Ala-Arg-7-amino-4- CAUGG) that matches perfectly the Kozak consensus sequence methylcoumarin (AMC), N-t-Boc-Gln-Gly-Arg-AMC, N-t-Boc- for translation initiation (16) and is immediately preceded by an Ala-Pro-Ala-AMC, and N-t-Boc-Ala-Phe-Lys-AMC. Routine as- in-frame UGA stop codon, strongly suggesting that this AUG says were performed at 37°C at substrate concentration of 100 ␮M corresponds to the true initiation site for this protein. Domain in an assay buffer containing 50 mM Tris⅐HCl (pH 8.0), 20 mM analysis using the SMART tool and the TMHMM (transmembrane NaCl, and 2.5% Me2SO. The fluorometric measurements were helices Markov model) program, indicated that the protein ␭ ϭ made in a MPF-44A Perkin–Elmer spectrofluorometer ( ex 360 possesses a type II transmembrane segment and a low-density ␭ ϭ nm, em 460 nm).
Recommended publications
  • Molecular Markers of Serine Protease Evolution
    The EMBO Journal Vol. 20 No. 12 pp. 3036±3045, 2001 Molecular markers of serine protease evolution Maxwell M.Krem and Enrico Di Cera1 ment and specialization of the catalytic architecture should correspond to signi®cant evolutionary transitions in the Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, Box 8231, St Louis, history of protease clans. Evolutionary markers encoun- MO 63110-1093, USA tered in the sequences contributing to the catalytic apparatus would thus give an account of the history of 1Corresponding author e-mail: [email protected] an enzyme family or clan and provide for comparative analysis with other families and clans. Therefore, the use The evolutionary history of serine proteases can be of sequence markers associated with active site structure accounted for by highly conserved amino acids that generates a model for protease evolution with broad form crucial structural and chemical elements of applicability and potential for extension to other classes of the catalytic apparatus. These residues display non- enzymes. random dichotomies in either amino acid choice or The ®rst report of a sequence marker associated with serine codon usage and serve as discrete markers for active site chemistry was the observation that both AGY tracking changes in the active site environment and and TCN codons were used to encode active site serines in supporting structures. These markers categorize a variety of enzyme families (Brenner, 1988). Since serine proteases of the chymotrypsin-like, subtilisin- AGY®TCN interconversion is an uncommon event, it like and a/b-hydrolase fold clans according to phylo- was reasoned that enzymes within the same family genetic lineages, and indicate the relative ages and utilizing different active site codons belonged to different order of appearance of those lineages.
    [Show full text]
  • Human LDLR / LDL Receptor Protein (His Tag)
    Human LDLR / LDL Receptor Protein (His Tag) Catalog Number: 10231-H08H General Information SDS-PAGE: Gene Name Synonym: FH; FHC; LDL R; LDL Receptor; LDLCQ2 Protein Construction: A DNA sequence encoding the extracellular domain of human LDLR (NP_000518.1) precursor (Met 1-Arg 788) was expressed with a C-terminal polyhistidine tag. Source: Human Expression Host: HEK293 Cells QC Testing Purity: > 85 % as determined by SDS-PAGE Bio Activity: Protein Description Measure by its ability to bind with human PCSK9 in a functional ELISA. LDL Receptor, also known as LDLR, is a mosaic protein which belongs to 1. Immobilized human PCSK9 at 10 μg/ml (100 μl/well) can bind the Low density lipoprotein receptor gene family. The low density lipoprotein biotinylated recombinant human LDLR. The EC of biotinylated human 50 receptor (LDLR) gene family consists of cell surface proteins involved in LDLR is 0.61 μg/ml. receptor-mediated endocytosis of specific ligands. LDL Receptor consists of 2. Immobilized mouse PCSK9 at 10 μg/ml (100 μl/well) can bind 84 amino acids (after removal of signal peptide) and mediates the biotinylated recombinant human LDLR. The EC50 of biotinylated human endocytosis of cholesterol-rich LDL. Low density lipoprotein (LDL) is LDLR is 0.12 μg/ml. normally bound at the cell membrane and taken into the cell ending up in Endotoxin: lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl < 1.0 EU per μg of the protein as determined by the LAL method coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis.
    [Show full text]
  • B1–Proteases As Molecular Targets of Drug Development
    Abstracts B1–Proteases as Molecular Targets of Drug Development B1-001 lin release from the beta cells. Furthermore, GLP-1 also stimu- DPP-IV structure and inhibitor design lates beta cell growth and insulin biosynthesis, inhibits glucagon H. B. Rasmussen1, S. Branner1, N. Wagtmann3, J. R. Bjelke1 and secretion, reduces free fatty acids and delays gastric emptying. A. B. Kanstrup2 GLP-1 has therefore been suggested as a potentially new treat- 1Protein Engineering, Novo Nordisk A/S, Bagsvaerd, Denmark, ment for type 2 diabetes. However, GLP-1 is very rapidly degra- 2Medicinal Chemistry, Novo Nordisk A/S, Maaloev, Denmark, ded in the bloodstream by the enzyme dipeptidyl peptidase IV 3Discovery Biology, Novo Nordisk A/S, Maaloev, DENMARK. (DPP-IV; EC 3.4.14.5). A very promising approach to harvest E-mail: [email protected] the beneficial effect of GLP-1 in the treatment of diabetes is to inhibit the DPP-IV enzyme, thereby enhancing the levels of The incretin hormones GLP-1 and GIP are released from the gut endogenously intact circulating GLP-1. The three dimensional during meals, and serve as enhancers of glucose stimulated insu- structure of human DPP-IV in complex with various inhibitors 138 Abstracts creates a better understanding of the specificity and selectivity of drug-like transition-state inhibitors but can be utilized for the this enzyme and allows for further exploration and design of new design of non-transition-state inhibitors that compete for sub- therapeutic inhibitors. The majority of the currently known DPP- strate binding. Besides carrying out proteolytic activity, the IV inhibitors consist of an alpha amino acid pyrrolidine core, to ectodomain of memapsin 2 also interacts with APP leading to which substituents have been added to optimize affinity, potency, the endocytosis of both proteins into the endosomes where APP enzyme selectivity, oral bioavailability, and duration of action.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Of Pseudomonas Aeruginosa Cristian Gustavo Aguilera Rossi1,2, Paulino Gómez-Puertas3 and Juan Alfonso Ayala Serrano2*
    Aguilera Rossi et al. BMC Microbiology (2016) 16:234 DOI 10.1186/s12866-016-0853-x RESEARCH ARTICLE Open Access In vivo functional and molecular characterization of the Penicillin-Binding Protein 4 (DacB) of Pseudomonas aeruginosa Cristian Gustavo Aguilera Rossi1,2, Paulino Gómez-Puertas3 and Juan Alfonso Ayala Serrano2* Abstract Background: Community and nosocomial infections by Pseudomonas aeruginosa still create a major therapeutic challenge. The resistance of this opportunist pathogen to β-lactam antibiotics is determined mainly by production of the inactivating enzyme AmpC, a class C cephalosporinase with a regulation system more complex than those found in members of the Enterobacteriaceae family. This regulatory system also participates directly in peptidoglycan turnover and recycling. One of the regulatory mechanisms for AmpC expression, recently identified in clinical isolates, is the inactivation of LMM-PBP4 (Low-Molecular-Mass Penicillin-Binding Protein 4), a protein whose catalytic activity on natural substrates has remained uncharacterized until now. Results: We carried out in vivo activity trials for LMM-PBP4 of Pseudomonas aeruginosa on macromolecular peptidoglycan of Escherichia coli and Pseudomonas aeruginosa. The results showed a decrease in the relative quantity of dimeric, trimeric and anhydrous units, and a smaller reduction in monomer disaccharide pentapeptide (M5) levels, validating the occurrence of D,D-carboxypeptidase and D,D-endopeptidase activities. Under conditions of induction for this protein and cefoxitin treatment, the reduction in M5 is not fully efficient, implying that LMM- PBP4 of Pseudomonas aeruginosa presents better behaviour as a D,D-endopeptidase. Kinetic evaluation of the direct D,D-peptidase activity of this protein on natural muropeptides M5 and D45 confirmed this bifunctionality and the greater affinity of LMM-PBP4 for its dimeric substrate.
    [Show full text]
  • Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected]
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School July 2017 Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Pathology Commons Scholar Commons Citation Mohamed, Mai, "Role of Amylase in Ovarian Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6907 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Role of Amylase in Ovarian Cancer by Mai Mohamed A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Pathology and Cell Biology Morsani College of Medicine University of South Florida Major Professor: Patricia Kruk, Ph.D. Paula C. Bickford, Ph.D. Meera Nanjundan, Ph.D. Marzenna Wiranowska, Ph.D. Lauri Wright, Ph.D. Date of Approval: June 29, 2017 Keywords: ovarian cancer, amylase, computational analyses, glycocalyx, cellular invasion Copyright © 2017, Mai Mohamed Dedication This dissertation is dedicated to my parents, Ahmed and Fatma, who have always stressed the importance of education, and, throughout my education, have been my strongest source of encouragement and support. They always believed in me and I am eternally grateful to them. I would also like to thank my brothers, Mohamed and Hussien, and my sister, Mariam. I would also like to thank my husband, Ahmed.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier Et Al
    US 200601 10747A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier et al. (43) Pub. Date: May 25, 2006 (54) PROCESS FOR IMPROVED PROTEIN (60) Provisional application No. 60/591489, filed on Jul. EXPRESSION BY STRAIN ENGINEERING 26, 2004. (75) Inventors: Thomas M. Ramseier, Poway, CA Publication Classification (US); Hongfan Jin, San Diego, CA (51) Int. Cl. (US); Charles H. Squires, Poway, CA CI2O I/68 (2006.01) (US) GOIN 33/53 (2006.01) CI2N 15/74 (2006.01) Correspondence Address: (52) U.S. Cl. ................................ 435/6: 435/7.1; 435/471 KING & SPALDING LLP 118O PEACHTREE STREET (57) ABSTRACT ATLANTA, GA 30309 (US) This invention is a process for improving the production levels of recombinant proteins or peptides or improving the (73) Assignee: Dow Global Technologies Inc., Midland, level of active recombinant proteins or peptides expressed in MI (US) host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant (21) Appl. No.: 11/189,375 protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recom (22) Filed: Jul. 26, 2005 binant protein expression. The process can improve protein production or can improve protein quality, for example, by Related U.S. Application Data increasing solubility of a recombinant protein. Patent Application Publication May 25, 2006 Sheet 1 of 15 US 2006/0110747 A1 Figure 1 09 010909070£020\,0 10°0 Patent Application Publication May 25, 2006 Sheet 2 of 15 US 2006/0110747 A1 Figure 2 Ester sers Custer || || || || || HH-I-H 1 H4 s a cisiers TT closers | | | | | | Ya S T RXFO 1961.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]
  • A Cut Above the Rest: the Regulatory Function of Plant Proteases
    Planta (2004) 220: 183–197 DOI 10.1007/s00425-004-1407-2 REVIEW Andreas Schaller A cut above the rest: the regulatory function of plant proteases Received: 13 July 2004 / Accepted: 15 September 2004 / Published online: 29 October 2004 Ó Springer-Verlag 2004 Abstract Proteolytic enzymes are intricately involved in peptidase Æ VPE: Vacuolar processing enzyme Æ Zn-MP: many aspects of plant physiology and development. On Zinc metalloprotease the one hand, they are necessary for protein turnover. Degradation of damaged, misfolded and potentially harmful proteins provides free amino acids required for the synthesis of new proteins. Furthermore, the selective breakdown of regulatory proteins by the ubiquitin/pro- Introduction teasome pathway controls key aspects of plant growth, development, and defense. Proteases are, on the other Plant scientists have long recognized protein turnover as hand, also responsible for the post-translational modi- a fundamental component in plant development. fication of proteins by limited proteolysis at highly Research interests, however, have traditionally focused specific sites. Limited proteolysis results in the matura- only on physiological processes relevant for agriculture, tion of enzymes, is necessary for protein assembly and including the breakdown of storage proteins during seed subcellular targeting, and controls the activity of en- germination, and protein remobilization upon the onset zymes, regulatory proteins and peptides. Proteases are of leaf senescence, concomitant with the reallocation of thus involved in all aspects of the plant life cycle ranging N resources to reproductive organs (Ryan and Walker- from the mobilization of storage proteins during seed Simmons 1981; Huffaker 1990). While these are still germination to the initiation of cell death and senescence highly active areas of research, we now begin to appre- programs.
    [Show full text]
  • Nudel, an Unusual Mosaic Protease Involved in Defining the Embryonic Dorsal-Ventral Axis of Drosophila Melanogaster Charles Chansik Hong Yale University
    Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine 5-1998 Nudel, an unusual mosaic protease involved in defining the embryonic dorsal-ventral axis of Drosophila Melanogaster Charles Chansik Hong Yale University. Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Part of the Medicine and Health Sciences Commons Recommended Citation Hong, Charles Chansik, "Nudel, an unusual mosaic protease involved in defining the embryonic dorsal-ventral axis of Drosophila Melanogaster" (1998). Yale Medicine Thesis Digital Library. 2217. http://elischolar.library.yale.edu/ymtdl/2217 This Open Access Dissertation is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. Nudel, an Unusual Mosaic Protease Involved in Defining the Embryonic Dorsal-Ventral Axis ofDrosophila Melanogaster A Dissertation Presented to the Faculty of the Graduate School o f Yale University in Candidacy for the Degree of Doctor of Philosophy by Charles Chansik Hong Dissertation Director: Carl Hashimoto, Ph.D. May, 1998 Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. © 1998 by Charles Chansik Hong All rights reserved. Reproduced with permission of the copyright owner. Further reproduction prohibited without permission. ABSTRACT Nudel, an Unusual Mosaic Protease Involved in Defining the Embryonic Dorsal-Ventral Axis ofDrosophila Melanogaster Charles Chansik Hong Yale University 1998 Dorsal-ventral polarity of Drosophilathe embryo is determined by positional information that originates outside of the embryo.
    [Show full text]
  • Sharon Carr Mphil Thesis
    ADENOVIRUS AND ITS INTERACTION WITH HOST CELL PROTEINS Sharon Carr A Thesis Submitted for the Degree of MPhil at the University of St. Andrews 2007 Full metadata for this item is available in Research@StAndrews:FullText at: http://research-repository.st-andrews.ac.uk/ Please use this identifier to cite or link to this item: http://hdl.handle.net/10023/219 This item is protected by original copyright Adenovirus and its interaction with host cell proteins Sharon Carr School of Biomedical Sciences University of St Andrews A thesis submitted for the degree of Master of Philosophy September 2006 1 I, …………………., hereby certify that this thesis, which is approximately 75,000 words in length, has been written by me, that it is the record of work carried out by me and that it has not been submitted in any previous application for a higher degree. date…………… signature of candidate………………………… I was admitted as a research student in September 2002 and as a candidate for the degree of Doctor of Philosophy in September 2002; the higher study for which this is a record was carried out in the University of St Andrews between 2002 and 2005, and at the University of Dundee between 2005 and 2006. date…………… signature of candidate………………………… I hereby certify that the candidate has fulfilled the conditions of the Resolution and Regulations appropriated for the degree of Master of Philosophy in the University of St Andrews and that the candidate is qualified to submit this thesis in application for that degree. date…………… signature of supervisors………………………… ………………………… 2 In submitting this thesis to the University of St Andrews I understand that I am giving permission for it to be made available for use in accordance with the regulations of the University Library for the time being in force, subject to any copyright vested in the work not being affected thereby.
    [Show full text]